Verici DX

(VRCI)
Sector: Pharmaceuticals & Biotechnology
0.60p
-0.06p -8.40
Last updated: 16:57:05

Director dealings

Trade date Director Volume / Price Trade value Trade type
24/07/2025 Ian James Carruthers 2,000,000 @ 0.50p £10,000.00 Placing
24/07/2025 Sara Barrington 4,000,000 @ 0.50p £20,000.00 Placing
24/07/2025 Julian Baines 4,000,000 @ 0.50p £20,000.00 Placing
03/11/2020 Ian James Carruthers 0 @ 0.00 0.00 Notification of Holding
03/11/2020 Barbara Therese Murphy 0 @ 0.00 0.00 Notification of Holding
03/11/2020 James Renwick McCullough 0 @ 0.00 0.00 Notification of Holding
03/11/2020 Julian Baines 0 @ 0.00 0.00 Notification of Holding

Director shareholdings

Name Holding Percent
Julian Baines 5,629,490 0.00%
Sara Barrington 4,000,000 0.00%
James Renwick McCullough 2,870,110 2.00%
Ian James Carruthers 2,100,000 0.00%

Major shareholders

Institution name Holding Percent
Maven Capital Partners UK LLP 186,390,843 13.07%
Puma Investment Management Limited 158,300,000 11.10%
Pentwater Capital Management LP 118,308,740 8.30%
Harwood Capital Management 37,646,569 15.52%
Christopher Mills 23,722,501 16.70%
Icahn School of Medicine at Mount Sinai 19,501,330 11.40%
Mount Sinai 18,427,216 13.00%
Amati Global Investors Limited 13,061,111 5.38%
Renalytix 9,831,681 5.80%
EKF Diagnostics Holdings Plc 9,820,838 5.77%
Unicorn Asset Management Limited 9,239,660 5.43%
Canaccord Genuity Group Inc 8,239,314 4.80%